Toronto wins bid to maintain exclusive market rights for Gilead in precedent-setting data protection case

Canada | November 02, 2020

Client: Gilead Sciences

Global law firm Norton Rose Fulbright successfully represented Gilead Sciences against the first-ever challenge of data protection rights for anti-HIV combination drug therapies.

Read full press release here.